过去一年中添加的文章,按日期排序

A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response

SL Leibel, RN McVicar, R Murad… - Proceedings of the …, 2024 - pubmed.ncbi.nlm.nih.gov
3 天前 - … The prevalence of "long COVID" is just one of the conundrums … stem cells and
emulating lung organogenesis, we generated and infected three-dimensional, multi-cell-type-…

Upregulation of key factors of viral entry of corona‐and influenza viruses upon‐signaling in cells from the respiratory tract and clinical treatment options by 1, 8‐Cineol

L Hose, M Schürmann, H Sudhoff - Phytotherapy Research, 2024 - pub.uni-bielefeld.de
3 天前 - … At the end of the 2019 coronavirus pandemic (COVID19)… , different variants of the
coronavirus currently cause most … epithelial stem cells and NRP1 in fibroblast cells. It seems …

Aplastic Anemia Following COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series

NL Cahuapaza-Gutierrez… - … and Stem Cell …, 2024 - ijhoscr.tums.ac.ir
5 天前 - … of hematopoietic stem cells by cytotoxic T cells. According to … vaccination against
coronavirus disease (COVID-19). … AA following vaccination against COVID-19 were included. …

MDS-Type Morphologic Abnormalities of Peripheral Blood Granulocytes in Symptomatic COVID-19 Patients

MJ Sharifi, N Gheibi, F Panahi… - … and Stem Cell …, 2024 - ijhoscr.tums.ac.ir
5 天前 - … Conclusion: Our results accounted for the possibility of active COVID-19 infection
in all subjects with granulocyte dysplasia. These results are of practical importance for …

[PDF][PDF] REGENERATIVE MEDICINE APPROACHES FOR TREATING COVID-19 DISEASE: A COMPREHENSIVE REVIEW

SK Mali, SK Gupta, RP Yadav, S Sharma, A Bilandi - researchgate.net
5 天前 - cell-tissue therapeutics products like stem cell therapy, exosomes, Chimeric antigen
receptor T-cell therapy, and natural killer cell … the management of COVID-19 disease by a …

[HTML][HTML] Diagnostic landscape of first-time cytometric screening for paroxysmal nocturnal hemoglobinuria in Poland in 2013–2022

J Spychalska, M Duńska, A Myślińska… - … Journal of Rare …, 2024 - ojrd.biomedcentral.com
6 天前 - … acquired hematopoietic stem cell disorder characterized … a median of 31 patients
(14 and 19 with clone sizes ≤ 1% … potentially influenced by the COVID-19 pandemic. The most …

[PDF][PDF] Upregulation of key factors of viral entry of corona-and influenza viruses upon TLR3-signaling in cells from the respiratory tract and clinical treatment options by …

L Hose, M Schürmann, H Sudhoff - Phytotherapy research: PTR, 2024 - researchgate.net
6 天前 - … At the end of the 2019 coronavirus pandemic (COVID-19), … , different variants of the
coronavirus currently cause most … epithelial stem cells and NRP1 in fibroblast cells. It seems …

[引用][C] Implications of acute coronavirus disease 2019 during haematopoietic stem cell transplantation—Experience from real‐world clinical practice

CSW Tham, J Quek, YC Linn, L Ng, A Ho, F Lim… - eJHaem - Wiley Online Library
10 天前 - … Patients diagnosed with COVID-19 within 120 days prior to stem cell infusion were
… with COVID-19 infection 3 days prior to stem cell infusion. He developed severe COVID-19

Human‐induced pluripotent stem cell‐derived hepatocyte platform in modeling of SARS‐CoV‐2 infection

R Zhang, R Wei, Y Yuan, N Li, Y Hu, KH Chan… - JGH …, 2024 - Wiley Online Library
11 天前 - … A large proportion of patients with COVID-19 developed liver injuries. The
human-induced pluripotent stem cell (iPSC)-derived hepatocytes recapitulate primary human …

Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: a pilot observational study

A Mastronuzzi, R Carsetti, MA De Ioris, C Agrati… - Heliyon, 2024 - cell.com
13 天前 - … of developing severe COVID-19 infection. We conducted a pilot prospective study
to evaluate the impact of cancer treatment and stem cell transplantation on immunogenicity of …